Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

ixabepilone 2aldesleukin 2Oxaliplatin 2sargramostim 1rF-B7.1 vaccine 1peginterferon alfa-2b 1indolepropanol phosphate 1fludarabine phosphate 1birinapant 1becatecarin 1alvocidib 1Topotecan 1Sorafenib 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1O(6)-benzylguanine 1Nitroarginine 1Methods 1Magnetic Resonance Spectroscopy 1Lapatinib 1Interleukin-2 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Early Intervention, Educational 1Docetaxel 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Unspecified Adult Solid Tumor, Protocol Specific × indolepropanol phosphate × Clear all
NCT00086970 2013-01-24

Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
32 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡